Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab-Reference-Cited by-同舟云学术

Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

Published:2019-10-03 Issue:4 Volume:75 Page:940-942
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Pérez de Llano Luis A.¹^ORCID,Dacal Rivas David¹,Cosío Borja G.²³^ORCID

Affiliation:

1. Pneumology Service Hospital Universitario Lucus Agusti EOXI Lugo, Cervo Monforte Spain

2. Department of Respiratory Medicine Hospital Universitario Son Espases‐IdISBa Palma de Mallorca, Mallorca Spain

3. CIBER de Enfermedades Respiratorias (CIBERES) Instituto de Salud Carlos III Madrid Spain

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14035

Reference6 articles.

1. The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

2. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

3. A pharmacodynamic model describing free IgE concentrations following administration of a recombinant humanized monoclonal anti IgE antibody in humans [abstract];Schoenhoff M;Pharm Res.,1995

4. Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆

5. Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics for severe asthma and beyond;Pharmacology & Therapeutics;2023-12

2. Characteristics of patients with severe asthma who experienced treatment failure with omalizumab;Pulmonary Pharmacology & Therapeutics;2021-06

3. Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma;The Journal of Allergy and Clinical Immunology: In Practice;2021-03

4. Impact of the Asthma Quality Assessment Program on Burden of Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2021-01

5. Clinical characteristics and treatment outcomes of severe asthma patients with a history of multiple biologic drugs use;Asian Pacific Journal of Allergy and Immunology;2021